CALL US:022-6101 1700   sales@saffronmedia.in
HOME NEWS INGREDIENT MART EVENTS TOPICS INTERVIEW EDIT
 

ARCHIVES FOR THE MONTH OF DECEMBER - 2023
 
HPMA urges health minister to stop risk-based inspections at manufacturing sites of MSMEs for one year
Navigating regulatory affairs in biopharma industry requires skilled talent pool: Expert
CRDMOs in India to create local supply eco-system, asserts itself as a bio-pharma sourcing powerhouse
Gujarat becomes first state to issue online licenses of medicines through newly launched FDCA-mDMLA mobile app
Generic dealer GFF in Jharkhand to embark on marketing in West Bengal, Bihar and Chattisgarh
Parliamentary Panel asks DoP to take adequate measures to make PTUAS more attractive
Pharma companies’ notable shift from air travel to ocean freight paves way for greener and eco-friendly transit option
Use of AI and automation among key market trends observed by Entod Pharma as part of decision-making process
DCGI directs manufacturers of common cold FDC to carry warning against use of drug in infants
Health minister says comments from stakeholders considered and incorporated in the New Bill
Maharashtra FDA unveils Rs. 24.59 crore strategy to overhaul drug regulatory system
Central legislation for regulation of Yoga and Naturopathy under consideration of Ministry of Ayush
Maharashtra FDA revokes 320 licenses, makes seizures worth Rs. 2.85 crore in illicit drug trade
Ayush ministry to amend D&C Rules to add guidelines & standards for new dosage form of nasal spray
FDI inflow into hospitals & diagnostic centres grows 59% in April-Sept, 2023
  • |
  • Current Page :
Back
 
INGREDIENT MART

RECENT NEWS

TOPICS
That foods might provide therapeutic benefits is clearly not a new concept. ...

 

MAIN LINKS OUR SERVICES OTHER PRODUCTS ONLINE MEDIA  
 
About Us
Contact Us
News Archives
 

Product Finder
Features and Articles
News
 
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
 
Media Information
Rate Card
Advertise
 
 
Copyright © 2023 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Chrome (103.0) or Firefox (90.0)